1. Foundations (Physiology / Functional Anatomy)

  • Thyroid Anatomy:

    • The thyroid is a butterfly-shaped gland located in the anterior neck, anterior to the trachea and just inferior to the laryngeal prominence. It is composed of two lobes connected by a narrow isthmus.

    • The gland is encapsulated and composed of numerous spherical follicles lined by cuboidal epithelial (follicular) cells. These cells synthesize and secrete thyroid hormones (T3 and T4).

    • The follicular lumen is filled with colloid, a proteinaceous substance rich in thyroglobulin, which serves as a reservoir for thyroid hormone precursors.

    • Interspersed among the follicles are parafollicular (C) cells, which secrete calcitonin, a hormone involved in calcium homeostasis by opposing parathyroid hormone (PTH).

    • Blood supply is rich, derived from the superior and inferior thyroid arteries, ensuring efficient hormone release into systemic circulation.

  • Hormone Synthesis:

    • Dietary iodine is absorbed in the small intestine and taken up by follicular cells through the sodium-iodide symporter (NIS) located on the basolateral membrane.

    • Once inside the cell, iodide is transported to the apical surface and oxidized to iodine by the enzyme thyroid peroxidase (TPO).

    • Iodine is then attached to tyrosine residues within thyroglobulin, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT).

    • TPO also catalyzes the coupling of iodinated tyrosine residues: MIT + DIT = T3, and DIT + DIT = T4.

    • The iodinated thyroglobulin is stored in colloid until stimulation by TSH prompts endocytosis back into the follicular cell and enzymatic cleavage of T3 and T4 for secretion.

    • T4 is secreted in greater quantities but is less active; it is converted to T3, the biologically active form, in peripheral tissues by 5’-deiodinase.

  • Regulation:

    • The hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH).

    • TSH binds to receptors on thyroid follicular cells, promoting iodine uptake, thyroglobulin synthesis, and enhanced activity of TPO, all leading to increased thyroid hormone synthesis.

    • T3 and T4 exert negative feedback inhibition on both the hypothalamus (reducing TRH) and pituitary (reducing TSH) to maintain hormone balance.

2. Disease Mechanisms (Pathophysiology)

  • Hyperthyroidism:

    • Graves Disease:

      • Most common cause of hyperthyroidism; autoimmune activation of the TSH receptor by thyroid-stimulating immunoglobulins (TSI).

      • Presents with diffuse goiter, exophthalmos (due to retro-orbital fibroblast activation), pretibial myxedema, and other systemic symptoms such as heat intolerance, weight loss, palpitations, anxiety, diarrhea, tremors, and menstrual irregularities.

      • Common in women aged 20–40, with associations to HLA-DR3 and HLA-B8.

    • Toxic Multinodular Goiter:

      • Arises from longstanding iodine deficiency or previous goiter; multiple hyperfunctioning nodules autonomously produce T3 and T4.

      • Lacks extrathyroidal manifestations such as exophthalmos; radioactive iodine scan shows patchy uptake.

    • Thyroid Storm:

      • Severe form of thyrotoxicosis precipitated by stressors (e.g., surgery, infection).

      • Presents with high fever, tachyarrhythmias, agitation, nausea/vomiting, delirium, and potentially fatal cardiovascular collapse.

      • Treated emergently with beta-blockers, PTU, corticosteroids, and iodide.

  • Hypothyroidism:

    • Hashimoto Thyroiditis:

      • Autoimmune lymphocytic infiltration leads to gradual thyroid failure.

      • Features include fatigue, cold intolerance, weight gain, dry skin, constipation, hair thinning, memory impairment, and menorrhagia.

      • Antibodies: Anti-TPO and anti-thyroglobulin. Histology reveals Hurthle cells and lymphoid aggregates with germinal centers.

      • Associated with HLA-DR5 and increased risk of B-cell (marginal zone) lymphoma.

    • Congenital Hypothyroidism (Cretinism):

      • Results from thyroid agenesis, dyshormonogenesis, maternal iodine deficiency, or maternal hypothyroidism.

      • Symptoms include macroglossia, umbilical hernia, hypotonia, jaundice, and poor brain development if untreated.

      • Early diagnosis and levothyroxine therapy are critical to prevent intellectual disability.

    • Subacute Granulomatous (De Quervain) Thyroiditis:

      • Typically follows viral infection (e.g., coxsackievirus).

      • Painful, tender thyroid with elevated ESR; initial hyperthyroidism followed by hypothyroidism.

      • Self-limited; histology shows granulomas and multinucleated giant cells.

    • Riedel Thyroiditis:

      • Rare fibrosing disease; dense collagen replaces normal tissue.

      • Hard, fixed, painless goiter that may cause dysphagia or airway obstruction.

      • May be part of IgG4-related systemic disease.

3. Pharmacology

  • Thionamides:

    • Methimazole and PTU inhibit TPO, reducing organification and coupling of iodine.

    • PTU additionally inhibits peripheral conversion of T4 to T3.

    • Methimazole is first-line except in the first trimester of pregnancy (due to teratogenicity) and thyroid storm (where PTU is preferred).

    • Side effects: Agranulocytosis (monitor CBC), hepatotoxicity (especially with PTU), and skin rash.

  • Levothyroxine:

    • Oral synthetic T4; used for primary hypothyroidism.

    • Administered on an empty stomach in the morning.

    • Dosing individualized based on TSH monitoring; caution in elderly and cardiac patients to avoid precipitating angina.

  • Beta-blockers (e.g., propranolol):

    • Control adrenergic symptoms of hyperthyroidism.

    • Non-selective beta-blockers also reduce peripheral conversion of T4 to T3.

  • Iodide (Lugol’s solution):

    • Blocks hormone release acutely via the Wolff-Chaikoff effect.

    • Used preoperatively to reduce thyroid vascularity.

  • Radioactive Iodine (I-131):

    • Oral administration leads to selective uptake by thyroid tissue, causing ablation.

    • Indicated for Graves disease, toxic nodules; contraindicated in pregnancy and breastfeeding.

4. Case Vignettes and Clinical Correlations

Vignette 1: A 28-year-old woman with a diffusely enlarged thyroid, exophthalmos, palpitations, and weight loss. Lab work reveals suppressed TSH and elevated free T4. TSI is positive. → Diagnosis: Graves Disease.

Vignette 2: A 55-year-old man presents with fatigue, dry skin, constipation, and weight gain. His TSH is elevated and T4 is low. Anti-TPO antibodies are detected. → Diagnosis: Hashimoto Thyroiditis.

Vignette 3: A middle-aged woman has anterior neck pain and tenderness after a flu-like illness. Lab shows transient hyperthyroidism with elevated ESR. → Diagnosis: Subacute (De Quervain) Thyroiditis.

5. Mnemonics

  • "Hot nodules = autonomous hormone producers" → show increased uptake.

  • "Hashimoto = Hurthle cells + Hypothyroid".

  • "Graves = Goiter, Glare, and Gasp".

  • "Cretinism = 6 Ps: Pot-bellied, Pale, Puffy-faced, Protruding umbilicus, Protruding tongue, Poor brain development".

6. Cross-System Integration

  • Cardiovascular:

    • Hyperthyroidism: ↑β1 activity → palpitations, atrial fibrillation.

    • Hypothyroidism: ↓cardiac output, pericardial effusion, bradycardia.

  • Neurological:

    • Hyperthyroidism: Agitation, insomnia, hyperreflexia.

    • Hypothyroidism: Lethargy, slow reflexes, depression.

  • Reproductive:

    • Hypothyroid women: Menorrhagia, infertility.

    • Hyperthyroid men: Gynecomastia; women: oligomenorrhea.

  • Dermatologic:

    • Graves: Warm skin, pretibial myxedema.

    • Hashimoto: Dry, coarse skin; non-pitting edema (myxedema).